Avante Logixx Inc. Announces Record Results for Q3 Ended

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
103
Avante Logixx Inc. Announces Record Results for Q3 Ended December 31, 2016

TORONTO, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Trading symbols: (TSX-V: XX ), (OTC:ALXXF)

Avante Logixx Inc., (“Avante” the “Company” or the “Group”) through its subsidiaries, Avante Security Inc. (“ASI”), INTO-Electronics Inc. (“INTO”) and City Wide Locksmiths Ltd. (“CWL”), provides best in class residential and commercial security and automation services including system design and installation, rapid alarm response, alarm monitoring, video analytics, commercial and high-rise security integration, secure transport, electronic building management and high-end lock services through the use of advanced technology and a focus on client service. The Company is pleased to announce its results for the quarter and nine month period ended December 31, 2016:

RESULTS FOR THE NINE MONTH PERIOD ENDED DECEMBER 31, 2016

  Quarter ended Nine month period ended
   Dec 31, 2016  Dec 31, 2015 Variance  Dec 31, 2016  Dec 31, 2015 Variance
             
Total revenues $ 5,788,796 $ 3,899,376   48.5 % $ 15,496,043 $ 10,749,203 44.2 %
Revenue - Other security services and transport   4,263,351   2,402,279   77.5 %   11,006,150   6,336,305 73.7 %
Revenue - Recurring Monitoring and Response [1]   1,525,445   1,497,097   1.9 %   4,489,892   4,412,898 1.7 %
Total gross profit   2,043,862   1,350,594   51.3 %   5,504,566   4,010,731 37.2 %
Adjusted EBITDA [2]   687,498   423,996   62.1 %   1,810,665   1,286,521 40.7 %
Net income before income tax [3]   464,128   (354,820 )     1,031,067   313,951  
Net income for the period   339,128   (304,821 )     760,075   179,966  
Basic and diluted income per share $ 0.004 $ (0.004 )   $ 0.008 $ 0.002  
             
Total common shares outstanding   81,532,052   81,375,802       81,532,052   81,382,052  
Total common shares outstanding - diluted   81,767,422   84,104,782       84,104,782   83,337,948  
             
Total assets $ 17,938,600 $ 15,160,343          
Total liabilities   6,148,515   4,399,134          
Total liabilities (excl. deferred revenue)   3,644,035   2,153,215          
Deferred revenue   2,504,481   2,245,919          
Shareholders' equity $ 11,340,884 $ 10,761,209          
Non-controlling interests $ 449,200   -           

During the quarter, the Company generated record revenues of $5,788,796, an increase of 48.5% over the quarter ended December 31, 2015. Non-recurring revenues grew by 77.5%, primarily driven by the inclusion of CWL revenues and significant organic growth in commercial security installations. The Company registered organic growth in non-recurring revenues for the quarter was approximately 16.0%. CWL, which was acquired on April 1, 2016, contributed $1,272,232 to the Company’s revenues for the quarter. The Company’s overall gross profit for the quarter was $2,043,862 or 35.3% as compared to $1,350,594 or 34.6% for the quarter ended December 31, 2015. The blended gross margin on rapid response, secure transport, international security travel advisory segment and monitoring services was 49.0% for the quarter ended December 31, 2016, as compared to 46.4% for the quarter ended December 31, 2015. Gross margin from installations was 17.7% for the quarter as compared to 16.6% for the same quarter in the prior year.  The improvement in margin on installations is attributable to efficiencies in the execution of system integration job orders. Adjusted EBITDA for the quarter amounted to $687,498 as compared to $423,996 for the quarter ended December 31, 2015, while net income for the quarter amounted to $339,128, as compared to a loss of $304,821 in the same quarter of last year. The loss in this quarter last year was attributable to certain integration costs amounting to $622,279, and increases in share based payments, depreciation and amortization.

For the nine month period, revenues grew by 44.2% over the same period last year. Non-recurring revenues grew by 73.7%, while recurring revenues grew by 1.7%. Non-recurring revenues showed organic growth of 14.6% for the nine month period. CWL’s contribution to the overall revenues amounted to $3,745,036 for the nine month period ended December 31, 2016. Gross margin for the nine month period was $5,504,566 or 35.5% as compared to $4,010,731 or 37.3% for the same period last year. Adjusted EBITDA for the nine month period ended December 31, 2016 amounted to $1,810,665 as compared to $1,286,521 for same period last year.

Avante’s CEO, George Rossolatos said, while commenting on the results for the quarter and the nine month period, “We are very pleased with the results for the third quarter. Certain initiatives which were put in place the end of the previous quarter are starting to yield results, particularly in the systems integration division. The integration of the technical services teams of ASI and INTO will further improve labour efficiencies, which will have a favourable impact on profitability.”

Over the past six months, CWL has been offering preferential rates on its offerings to existing Avante customers. This initiative has been received very well by the customers, resulting in incremental revenues for CWL and the Company. Also, the showroom in which all the offerings of the Company are on display has already caught the attention of regular customers. The Company believes that this could have a significant impact in improving the top line of the Company in the coming quarters.

Avante’s acquisitions over the past two years have been performing well. Avante also continues to pursue several acquisition targets and is hopeful of closing one before the end of the current fiscal year.

CONFERENCE CALL

As announced on Tuesday, February 21, 2017, Avante will be hosting a conference call to discuss the aforementioned results on Monday, February 27, 2017 at 8:30 AM EST.

Dial in details are as follows:  

Local: (+1) 416-764-8658            Toll Free: (+1) 888-886-7786                   Conference ID: 42701904

Playback details below, available until March 13, 2017:

Local: (+1) 416-764-8692            Toll Free: (+1) 877-674-7070                   Playback Pin: 701904#

About Avante Logixx ( www.avantelogixx.com ) Avante Logixx Inc. (TSXV:XX) is a Toronto based security, monitoring, system integration and technology company. Its subsidiaries, Avante Security Inc. ( www.avantesecurity.com ), INTO Electronics Inc., ( www.247into.com ), and the recently acquired City Wide Locksmiths Ltd. ( www.citywidelocksmith.ca ) together provide best in class security systems and services for residential and commercial clients, and high-rise condominium applications, with industry leadership in designing and installing complex security systems, access control, intelligent video analytics, high-end lock services and smart home automation. Avante’s group of companies strives to be best in class in each of its verticals including an industry leading rapid alarm response offering combined with alarm system and live video analytics monitoring. Avante’s Executive Services team provides unparalleled end-to-end security solutions for high profile and high net worth families to ensure their safety in a comprehensive yet discrete manner, including an executive transportation option. Avante’s International Travel Security team helps corporations protect traveling employees working abroad in medium/high risk jurisdictions and has executed travel details in over 60 countries. Avante continuously develops innovative products and applications within its core competencies. Please visit our website at www.avantelogixx.com  and consider joining our investor email list.

Avante Logixx Inc.

George Rossolatos CEO (416) 923-6984 x221 george@avantelogixx.com

Leland Verner Chairman (416) 823-7474 leland@avantelogixx.com

FORWARD LOOKING STATEMENTS

All statements in this press release, other than statements of historical fact, are “forward looking information” with respect to Avante within the meaning of applicable securities laws. Forward-looking information is often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “planned”, “expect”, “project”, “predict”, “potential”, “targeting”, “intends”, “believe”, “potential”, and similar expressions, or describes a “goal”, or a variation of such words and phrases or state that certain actions, events or results “may”, “should”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

Forward-looking information is subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those expressed or implied by the forward-looking information, including, without limitation, the list of risk factors identified in Avante’s Management Discussion & Analysis (MD&A), Annual Information Form (AIF) and other continuous disclosure, which list is not exhaustive of the factors that may affect any of Avante’s forward-looking information. In connection with the forward-looking statements contained in this and subsequent press releases, Avante has made certain assumptions about its business and the industry in which it operates and has also assumed that no significant events occur outside of Avante’s normal course of business. Although management believes that the assumptions inherent in the forward-looking statements are reasonable as of the date the statements are made, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein. Avante’s forward-looking information is based on the beliefs, expectations and opinions of management on the date the statements are made, and Avante does not assume any obligation to update forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable law. For the reasons set forth above, readers should not place undue reliance on forward-looking information.

NON-IFRS MEASURES

References to EBITDA are to net income before interest, taxes, depreciation and amortization. References to Adjusted EBITDA are to net income plus interest, taxes, depreciation and amortization and charges for share-based payments and integration and acquisition costs. Neither EBITDA nor Adjusted EBITDA is an earnings measure recognized by International Financial Reporting Standards ("IFRS") and do not have a standardized meaning prescribed by IFRS. Management believes that Adjusted EBITDA is an appropriate measure in evaluating Avante's performance. Readers are cautioned that neither EBITDA nor Adjusted EBITDA should be construed as an alternative to net income (as determined under IFRS), as an indicator of financial performance or to cash flow from operating activities (as determined under IFRS) or as a measure of liquidity and cash flow. Avante's method of calculating Adjusted EBITDA may differ from methods used by other issuers and, accordingly, Avante's Adjusted EBITDA may not be comparable to similar measures used by other issuers.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

____________________________

1   Revenues – Recurring Monitoring and Response includes Alarm Response along with Digital, Wireless and Video Monitoring services

2   Adjusted EBITDA = Net income + income tax + depreciation / amortization + shared based payments expense + acquisition and integration costs

3   Share based payments and acquisition related amortization increased by $138,420 and $158,500 for the nine month period

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading